| abstract |
The present invention has the formula (1) [Chemical 1] (Wherein X represents SO or SO 2 , preferably SO, and R 1 , R 2 and R 3 have the meanings indicated in the specification) As well as their pharmacologically acceptable salts, diastereomers, enantiomers, racemates, hydrates or solvates (these are respiratory or gastrointestinal diseases or disorders, joints, skin Or suitable for the treatment of inflammatory diseases of the eye, diseases of the peripheral or central nervous system, or cancer) as well as pharmaceutical compositions comprising this compound. |